blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1289521

EP1289521 - COMBINATION OF LIPOIC ACID AND C 1 DONORS FOR THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  14.11.2008
Database last updated on 03.10.2024
Most recent event   Tooltip14.11.2008Refusal of applicationpublished on 17.12.2008  [2008/51]
Applicant(s)For all designated states
BASF SE
Carl-Bosch-Strasse 38
67056 Ludwigshafen am Rhein / DE
[N/P]
Former [2008/10]For all designated states
BASF SE
67056 Ludwigshafen / DE
Former [2003/11]For all designated states
BASF AKTIENGESELLSCHAFT
67056 Ludwigshafen / DE
Inventor(s)01 / HÄHNLEIN, Wolfgang
Am Rosenbühl 11a
67251 Freinsheim / DE
02 / KRÄMER, Klaus
Daniel-Knobloch-Strasse 4
76829 Landau / DE
03 / HASSELWANDER, Oliver
Hamburger Strasse 52
76829 Landau / DE
04 / MÜLLER, Walter, E.
Höhenstrasse 49a
67550 Worms / DE
05 / ECKERT, Günther, P.
Erlenweg 20
65835 Liederbach a.T. / DE
 [2003/11]
Representative(s)Kinzebach, Werner, et al
Reitstötter, Kinzebach & Partner Patentanwälte Sternwartstrasse 4
81679 München / DE
[N/P]
Former [2003/11]Kinzebach, Werner, Dr., et al
Patent Attorneys, Reitstötter, Kinzebach & Partner, Sternwartstrasse 4
81679 München / DE
Application number, filing date01945113.710.05.2001
[2003/11]
WO2001EP05359
Priority number, dateDE200012285610.05.2000         Original published format: DE 10022856
[2003/11]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report
No.:WO0185165
Date:15.11.2001
Language:DE
[2001/46]
Type: A2 Application without search report 
No.:EP1289521
Date:12.03.2003
Language:DE
The application published by WIPO in one of the EPO official languages on 15.11.2001 takes the place of the publication of the European patent application.
[2003/11]
Search report(s)International search report - published on:EP02.05.2002
ClassificationIPC:A61K31/385, A61K31/7076, A61K31/519, A61P25/00, // A61K31:7076, A61K31:385, A61K31:519, A61K31:385
[2003/11]
CPC:
A61K31/385 (EP,US); A61K31/519 (EP,US); A61K31/7076 (EP,US);
A61P25/00 (EP); A61P25/24 (EP); A61P25/28 (EP)
C-Set:
A61K31/385, A61K2300/00 (EP,US);
A61K31/519, A61K2300/00 (US,EP);
A61K31/7076, A61K2300/00 (US,EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/11]
Extension statesALNot yet paid
LT09.12.2002
LV09.12.2002
MKNot yet paid
RO09.12.2002
SI09.12.2002
TitleGerman:KOMBINATION VON LIPONSÄURE UND C 1-DONOREN ZUR BEHANDLUNG VON STÖRUNGEN DES ZENTRALEN NERVENSYSTEMS[2003/11]
English:COMBINATION OF LIPOIC ACID AND C 1 DONORS FOR THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM[2003/11]
French:COMBINAISON D'ACIDE LIPOIQUE ET DE DONNEURS D'UNITES C 1 POUR LE TRAITEMENT DE TROUBLES DU SYSTEME NERVEUX CENTRAL[2003/11]
Entry into regional phase09.12.2002National basic fee paid 
09.12.2002Designation fee(s) paid 
09.12.2002Examination fee paid 
Examination procedure05.12.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
09.12.2002Examination requested  [2003/11]
09.03.2004Despatch of a communication from the examining division (Time limit: M07)
19.10.2004Reply to a communication from the examining division
28.10.2005Despatch of a communication from the examining division (Time limit: M08)
16.08.2006Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
25.10.2006Reply to a communication from the examining division
12.03.2008Cancellation of oral proceeding that was planned for 14.03.2008
12.03.2008Minutes of oral proceedings despatched
14.03.2008Date of oral proceedings
14.03.2008Date of oral proceedings (cancelled)
31.07.2008Despatch of communication that the application is refused, reason: substantive examination [2008/51]
10.08.2008Application refused, date of legal effect [2008/51]
Request for further processing for:25.10.2006Request for further processing filed
25.10.2006Full payment received (date of receipt of payment)
Request granted
08.11.2006Decision despatched
Fees paidRenewal fee
26.03.2003Renewal fee patent year 03
05.05.2004Renewal fee patent year 04
13.05.2005Renewal fee patent year 05
27.03.2006Renewal fee patent year 06
07.05.2007Renewal fee patent year 07
18.03.2008Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]FR4630M  (C.E.R.E.T.) [X] 7-9 * siehe insbesondere S. 1, linke Spalte, Z. 5-9; S. 2, linke Spalte, 2. Formel; S. 2, rechte Spalte, vorletzer Paragraph *;
 [Y]US4057686  (FIECCHI ALBERTO) [Y] 1-9 * siehe insbesondere Spalte 22, Z. 47 - Spalte 23, Z. 59 *;
 [YD]EP0388827  (BIORESEARCH SPA [IT]) [YD] 1-9 * siehe insbesondere S. 6-7, Tabelle 3; Fig. 2 und 3; Anspruch 1 *;
 [X]US5292538  (PAUL STEPHEN M [US], et al) [X] 7-9 * siehe insbesondere Spalte 1, Z. 15-26; Spalten 11 und 12 *;
 [Y]DE4343592  (ASTA MEDICA AG [DE]) [Y] 1-9 * siehe insbesondere S. 2, Z. 24-26; S. 4, Z. 48-65; Anspruch 1 *;
 [DY]  - STOLL, S. (1) ET AL, "The potent free radical scavenger alpha - lipoic acid improves cognition in rodents.", ZS.-NAGY, I. [EDITOR];HARMAN, D. [EDITOR]; KITANI, K. [EDITOR]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, (1994) VOL. 717, PP. 122-128. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES; PHARMACOLOGY OF AGING PROCESSES: METHODS OF ASSESSMENT AND POTENTIAL, XP001029748 [DY] 1-9 * siehe insbesondere S. 122, Einleitung; S. 126 und S. 127, Diskussion; Fig. 2 *

DOI:   http://dx.doi.org/10.1111/j.1749-6632.1994.tb12079.x
 [Y]  - PASSERI M ET AL, "ORAL 5 METHYLTETRAHYDROFOLATE MTHF IN DEPRESSION ASSOCIATED WITH SENILE ORGANIC MENTAL DISORDERS OMDS A DOUBLE-BLIND MULTICENTER STUDY VS TRAZODONE TRZ.", 25TH MEETING OF THE EUROPEAN SOCIETY FOR CLINICAL INVESTIGATION, PISA, ITALY, APRIL 3-6, 1991. EUR J CLIN INVEST. (1991) 21 (2 PART 2), 24., XP001029044 [Y] 1-9 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.